Browse > Article
http://dx.doi.org/10.15324/kjcls.2022.54.2.110

Frequency of Candida Strains Isolated from Candidiasis Patients at A Tertiary Hospital over the Last 10 Years  

Hwang, Yu-Yean (Department of Laboratory Medicine, Samsung Medical Center)
Kang, On-Kyun (Department of Laboratory Medicine, Samsung Medical Center)
Park, Chang-Eun (Department of Biomedical Laboratory Science, Molecular Diagnostics Research Institute, Namseoul University)
Hong, Sung-No (Department of Clinical Laboratory Science, Dongnam Health University)
Kim, Young-Kwon (Department of Health Sciences, The Graduate School of Konyang University)
Huh, Hee-Jae (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Nam-Yong (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
Korean Journal of Clinical Laboratory Science / v.54, no.2, 2022 , pp. 110-118 More about this Journal
Abstract
Candidemia is a major cause of nosocomial infections resulting in increased morbidity and mortality. It remains a serious risk in inpatients and increases medical treatment costs. From 2009 to 2018, Candida strains (3,533) isolated from blood culture tests at the S Hospital were analyzed according to the period, year, sex, age, ward, etc. During the entire period, 54,739 of 717,996 blood culture tests showed a positive rate (7.6%) and the Candida isolation rate was 3,533 (6.4%) out of 1,036 patients. Among the Candida isolates, C. albicans was most common (33.8%), followed by C. tropicalis (28.6%), C. glabrata (19.8%), C. parapsilosis (7.8%), and C. krusei (4.0%). In early (2009~2013)/late (2014~2018) isolation, C. tropicalis decreased by 3.8% and C. glabrata increased by 3.4%. After 50 years of age, the higher the separation frequency. C. parapsilosis (31.3%) in 1~10s, C. tropicalis (30.3%) and C. glabrata (27.6%) in 41~50s, and C. tropicalis (28.6%) in 80s are relatively frequent. has been separated C. krusei was isolated in a relatively high proportion from females (60.9%). Therefore, a systematic and continuous nosocomial infection control system should be established for appropriate treatment as per antifungal treatment guidelines. The system should continuously monitor the distribution of Candida species and provide rapid identification results.
Keywords
Blood culture; Candidemia; Candida bloodstream infections; Candida species; Non albicans Candida species;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73:45-48. https://doi.org/10.1016/j.diagmicrobio.2012.02.001   DOI
2 Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011;49:3300-3308. https://doi.org/10.1128/JCM.00179-11   DOI
3 Ding X, Yan D, Sun W, Zeng Z, Su R, Su J. Epidemiology and risk factors for nosocomial non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol. 2015;53:684-690. https://doi.org/10.1093/mmy/myv060   DOI
4 Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21:938-945. https://doi.org/10.1016/j.cmi.2015.06.008   DOI
5 Won EJ, Shin JH, Lee WK, Koo SH, Kim SY, Park YJ, et al. Distribution of yeast and mold species isolated from clinical specimens at 12 hospitals in Korea during 2011. Ann Clin Microbiol. 2013;16:92-100. https://doi.org/10.5145/ACM.2013.16.2.92   DOI
6 Kumar S, Kalam K, Ali S, Siddiqi S, Baqiet S. Frequency, clinical presentation and microbiological spectrum of candidemia in a tertiary care center in Karachi, Pakistan. J Pak Med Assoc. 2014;64:281-285.
7 Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, et al. High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a prospective observational study in Taiwan. PLoS One. 2015;10:e0128410. https://doi.org/10.1371/journal.pone.0128410   DOI
8 Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73:i4-i13. https://doi.org/10.1093/jac/dkx444   DOI
9 Kim D, Hwang GY, Yoo G, Kim J, Uh Y, et al. Trend of prevalence and antifungal drug resistance of Candida species isolated from candidemia patients at a tertiary care hospital during recent two decades. Ann Clin Microbiol. 2017;20:53-62. https://doi.org/10.5145/ACM.2017.20.3.53   DOI
10 Won EJ, Choi MJ, Kim MN, Yong D, Lee WG, Uh Y, et al. Fluconazole-resistant Candida glabrata bloodstream isolates, South Korea, 2008-2018. Emerg Infect Dis. 2021;27:779-788. https://doi.org/10.3201/eid2703.203482   DOI
11 World Health Organization. Antimicrobial resistance global report on surveillance 2014. [cited 2022 January 14]. Available from: https://apps.who.int/iris/bitstream/handle/10665/112647/WHO_HSE_PED_AIP_2014.2_eng.pdf
12 Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503-509. https://doi.org/10.1086/590004   DOI
13 Gilgado F, Serena C, Cano J, Gene J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50:4211-4213. https://doi.org/10.1128/AAC.00981-06   DOI
14 Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018:73:891-899. https://doi.org/10.1093/jac/dkx480   DOI
15 Balk RA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clinics. 2000;16:179-192. https://doi.org/10.1016/s0749-0704(05)70106-8   DOI
16 Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, et al. Candida auris clinical isolates from South Korea: Identification, antifungal susceptibility, and genotyping. J Clin Microbiol. 2019:57;e01624-18. https://doi.org/10.1128/JCM.01624-18   DOI
17 Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, et al. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis. 2007;59:407-414. https://doi.org/10.1016/j.diagmicrobio.2007.06.008   DOI
18 Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis. 2006;25:419-425. https://doi.org/10.1007/s10096-006-0159-2   DOI
19 Taei M, Chadeganipour M, Mohammadi R. An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents. BMC Res Notes. 2019;12:779. https://doi.org/10.1186/s13104-019-4811-1   DOI
20 Lopez Dupla M, Martinez JA, Vidal F, Almela M, Lopez J, Marco F, et al. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes. J Intern Med. 2005;258:172-180. https://doi.org/10.1111/j.1365-2796.2005.01513.x   DOI
21 Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501-509. https://doi.org/10.1111/1469-0691.12195   DOI
22 Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: A narrative review. Eur J Intern Med. 2016;34:21-28. https://doi.org/10.1016/j.ejim.2016.06.029   DOI
23 Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50. https://doi.org/10.1093/cid/civ933   DOI
24 Colombo AL, Guimaraes T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;40:1489-1498. https://doi.org/10.1007/s00134-014-3400-y   DOI
25 Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One. 2015;10:e0120452. https://doi.org/10.1371/journal.pone.0120452   DOI
26 Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38:311-320. https://doi.org/10.1086/38063   DOI
27 Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14:e954-e966. https://doi.org/10.1016/j.ijid.2010.04.006   DOI
28 Kim JS, Gong SY, Kim JW, Rheem I, Kim GY. Antimicrobial susceptibility patterns of microorganisms isolated from blood culture during the last 8 years: 2010-2017. Korean J Clin Lab Sci. 2019;51:155-163. https://doi.org/10.15324/kjcls.2019.51.2.155   DOI
29 Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011;39:665-670. https://doi.org/10.1097/CCM.0b013e318206c1ca   DOI